2025-524034-26-02招募中1 期
A randomized, placebo-controlled trial, to evaluate the safety, immunogenicity and the optimal dose of MOPEVAC-Las vaccine candidate against Lassa Fever, in healthy volunteers consisting of an unblinded dose escalation and a blinded treatment phase (FIRST-IN-MOP)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 72
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Nathalie Jolly
Scientific
Institut Pasteur
研究点 (2)
Loading locations...
相似试验
招募中
1 期
A Pilot, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Tolerability, Safety, and Pharmacokinetics of a Single Intra-articular Injection of CNTX-0066 in Participants with Chronic, Moderate-to-Severe Osteoarthritis Knee Pain2025-523737-26-00Centrexion Therapeutics Corp.20
进行中（未招募）
3 期
To evaluate the effectiveness and safety of Metaberine versus placebo in healthy adultsCTRI/2026/07/113529Zeus Hygia LifeSciences Pvt Ltd100
招募中
1 期
A Phase 1, Randomized, Placebo-controlled Study with a Double-blind Period with Open-label Extension Period to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ALN-5288 in Adult Patients with Alzheimer’s Disease2025-522582-30-00Alnylam Pharmaceuticals Inc.7
进行中（未招募）
不适用
A clinical trial to study the effectiveness of combining a homoeopathic medicine with physiotherapy compared to a placebo with physiotherapy in improving symptoms and clinical severity for patients with varicose veins.CTRI/2026/07/114164Ahmedabad Homoeopathic Medical College attached to Sainath Hospital60
招募中
1 期
A randomized, double-blind, placebo-controlled clinical trial to investigate the human monoclonal antibody NG004 in acute, incomplete cervical spinal cord injury (SCI) patientsAcute Incomplete Cervical Spinal Cord Injury2026-526089-26-00NovaGo Therapeutics AG84